Hyloris Pharmaceuticals
People
16
Locations
1
Publications
30
Company Profile
Founded Date
April 10, 2017
Last Balance Sheet Year
2024
Juridical Form
Naamloze vennootschap
Enterprise Type
Rechtspersoon
Activity
82990 - Overige zakelijke dienstverlening, neg
Company Age
9 years
Contact Details
Unlock direct contact points, registry address detail, and website links for Hyloris Pharmaceuticals.
Unlock Contact Details
Reveal email, phone, website, and full registry contact information.
Create Free AccountHistorical Financials
| KPI | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | €5,966,698 (+432.5%) | €1,120,551 (-7.0%) | €1,204,885 (-56.7%) |
| Gross Margin | - | - | - |
| Profit | -€14,391,206 (-323.0%) | -€3,402,312 (-276.6%) | -€903,445 (+88.2%) |
| EBITDA | -€4,443,765 (-109.8%) | -€2,118,116 (+15.3%) | -€2,500,177 (+67.2%) |
| Equity | €88,360,668 (-14.0%) | €102,751,874 (-3.4%) | €106,320,976 (+18.9%) |
| Debt | €6,885,530 (-37.0%) | €10,924,769 (-4.6%) | €11,453,196 (-23.2%) |
| Total Assets | €95,663,227 (-16.6%) | €114,704,491 (-2.7%) | €117,830,790 (+11.4%) |
| Cash | €22,390,031 (+19.0%) | €18,817,284 (+310.0%) | €4,589,023 (-78.8%) |
| FTE | 1.9 (-24.0%) | 2.5 (+177.8%) | 0.9 |
Unlock Full History
Create a free account to access up to 10 years of historical financial data for Hyloris Pharmaceuticals.
Create Free AccountFinancial Health
Ratio-level insight derived from the latest company and balance sheet data.
Current Ratio
4.9x
(+49.1%)
Quick Ratio
4.9x
(+49.1%)
Solvency
92.4%
(+3.1%)
Debt / Equity
0.1x
Unlock Advanced Metrics
Access the full ratio deck, benchmarking signals, and deeper profitability diagnostics.
Create Free AccountLocations & Footprint
Establishment
AddressBoulevard de Patience et Beaujonc 3, 4000 Luik, Belgium
Entity Network
First-level relations linked directly to Hyloris Pharmaceuticals. Unlock second-level relations for deeper graph exploration.
Hyloris Pharmaceuticals
Active
- Jacobsen Management
Incoming link
Administrator Legal - NOSHAQ PARTNERS
Incoming link
Administrator Legal - SVR Management
Incoming link
Administrator Legal -
Carolyn Jane Myers
Incoming link
Administrator Natural -
James Charles Gale
Incoming link
Administrator Natural -
Marc Foidart
Incoming link
Administrator Natural -
Revital Rattenbach
Incoming link
Administrator Natural -
Stefan Yee
Incoming link
Administrator Natural -
Vincent Van Dessel
Incoming link
Administrator Natural - DERMAX
Incoming link
Participating Interest - DVP Invest
Outgoing link
Participating Interest - FHP
Incoming link
Participating Interest - Hyloris
Incoming link
Participating Interest - Hyloris Developments
Incoming link
Participating Interest - SAFFELBERG INVESTMENTS
Incoming link
Shareholder Entity - SCORPIAUX
Incoming link
Shareholder Entity -
Dietmar Aichhorn
Incoming link
Shareholder Individual -
Jean-Luc Vandenbroek
Incoming link
Shareholder Individual -
Koenraad Vanderlelst
Incoming link
Shareholder Individual -
Nick Reunbrouck
Incoming link
Shareholder Individual -
Pieter Van Rompay
Incoming link
Shareholder Individual -
Stijn Van Rompay
Incoming link
Shareholder Individual -
Thomas Jacobsen
Incoming link
Shareholder Individual -
Chris Buyse
Incoming link
Administrator Legal Representative -
Chris Buysse
Incoming link
Administrator Legal Representative -
Léon Van Rompay
Incoming link
Administrator Legal Representative -
Marc Foidart
Incoming link
Administrator Legal Representative -
Stijn Van Rompay
Incoming link
Administrator Legal Representative -
Thomas Jacobsen
Incoming link
Administrator Legal Representative
Unlock Second-Level Relations
Expand beyond direct links to see second-level entities, people, and cross-company paths.
Free Sign UpManagement & Key People
Unlock linked people, governance roles, and enriched demographic signals associated with Hyloris Pharmaceuticals.
Management Profiles
Unlock directors, managers, role history, plus inferred gender and age where available.
Create Free Account